Currently, access to a definitive genetic diagnosis in pediatric epilepsy remains limited, as evidenced by the 5–8-year diagnostic odyssey that many children face. 1 While patients may receive ...
"While epilepsy is a fairly common condition, affecting nearly a half a million children under age 18 in the US, its genetic origins are still insufficiently understood. Through increased access ...
For pediatric kids aged two to five with seizure clusters, Aquestive Therapeutics (AQST, Financials) said that the U.S. Food and Drug Administration has given seven years of orphan drug exclusivity to ...